SCHEMBL9538003

SCHEMBL9538003

CC(Cc1ccc2ccccc2c1)(OC(N)=O)C(=O)NCCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 1/20 0.46
CASR P41180 4/20 0.44
CYP2D6 P10635 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
KCNH2 Q12809 1/20 0.44
CES2 O00748 1/20 0.43
CCKBR P32239 1/20 0.43
NPC1 O15118 8/20 0.43
RAB9A P51151 8/20 0.43
MAPT P10636 5/20 0.42
POLB P06746 1/20 0.42
OPRK1 P41145 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
ALOX12 P18054 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9538757 0.82 MTNR1A (0.50) MMP8CCKBRNPC1RAB9AMAPT
SCHEMBL9539150 0.82 CYP26B1 (0.44) MMP8NPC1RAB9AMAPTPOLB
SCHEMBL9539323 0.82 MMP8 (0.51) MMP8NPC1RAB9AMAPTPOLB
SCHEMBL9541051 0.82 MMP8 (0.44) MMP8NPC1RAB9AMAPTPOLB
SCHEMBL9541636 0.81 MMP8 (0.49) MMP8CCKBRNPC1RAB9AMAPT
SCHEMBL9698478 0.78 CCKBR (0.54) MMP8CASRCYP2D6SLC6A2SLC6A4
SCHEMBL9700657 0.78 MMP8 (0.46) MMP8NPC1RAB9AMAPTPOLB
SCHEMBL14615486 0.76 CES2 (0.52) MMP8CES2MAPTPOLBALDH1A1
SCHEMBL9538098 0.75 MMP8 (0.44) MMP8CCKBRNPC1RAB9AMAPT
SCHEMBL9539180 0.75 MMP8 (0.44) MMP8NPC1RAB9AMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1993003721-A1 CHOLECYSTOKININ ANTAGONISTS USEFUL FOR TREATING DEPRESSION WARNER-LAMBERT COMPANY (US) 1993-03-04 WO disclosed